Form D · Pharmaceuticals

Balanced Pharma Inc

Cornelius, NC · CIK 0001838860

Offering snapshot reported Sep 23, 2025 · SEC filing

Reported sold: $3.2M
Investors reported: 1
Minimum accepted: $0
First sale: Nov 27, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,000,000 → $3,200,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 23, 2025	Amendment	$3,200,000	$1,200,000vs Dec 12, 2024	1	SEC filing
Jan 15, 2025	Initial	$175,000	No comparison	2	SEC filing
Dec 12, 2024	Initial	$2,000,000	No comparison	1	SEC filing
Dec 12, 2024	Initial	$498,000	No comparison	19	SEC filing
Feb 18, 2022	Amendment	$2,011,300	$1,530,175vs Jan 7, 2021	44	SEC filing
Jan 7, 2021	Initial	$481,125	No comparison	8	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-531847

Source: Form D, filed Sep 23, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
John Scott Keadle	Director, Executive
Richard Nonelle	Director
Mark Sebree	Director
John Selig	Director
Atif Zia	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

18204 Mainsail Pointe
Cornelius, NC, 28031
Phone: (704) 650-0249